Marcelo Leite

After President Richard Nixon declared the War on Drugs in 1971, clinical research on psychedelics remained stifled for three decades, amounting to a sure career-stopper in biomedical science for researchers. This state of affairs started to change with the advent of the twenty-first century and the renewed attention attracted by the so-called “psychedelic renaissance.” The promise of revolutionary therapies for mental disorders has grown to the point of generating an excess of interest from the part of investors. As a result, their rush to secure patent rights over age-old substances and healing practices now risks jeopardizing that very flurry of research… continue reading.

Comments are closed.